CDKN2A/p16 (9p21) homozygous deletion or overexpression of cyclin D1 overcomes EBV-induced senescence and allows stable EBV infection in cell lines, further supporting these molecular alterations as early events. This evidence concerns the gene CDKN2A and Epstein-Barr virus infection.